Abstract Objective To study the clinical effect of vitamin D3 (VitD3) combined with the Early Start Denver Model (ESDM) in the treatment of autism spectrum disorder (ASD) in toddlers. Methods A total of 102 toddlers with ASD, aged 1 to 3 years, were enrolled. According to the wishes of their parents, they were divided into conventional rehabilitation, ESDM and ESDM+VitD3 groups. Autism Behavior Checklist (ABC) and Childhood Autism Rating Scale (CARS) were used evaluate behavior problems before treatment and after 3 months of treatment. Results The conventional rehabilitation group had significant reductions in the total score and the scores on somatic movement and self-care subscales of the ABC scale after 3 months of treatment (P < 0.05). After 3 months of treatment, the ESDM group had significant reductions in the total score and the scores on somatic movement, self-care, social interaction and language subscales of the ABC scale (P < 0.05), as well as a significant reduction in the total score of the CARS (P < 0.05). After 3 months of treatment, the ESDM+VitD3 group had a significant increase in the level of 25(OH)D and significant reductions in the total score and the scores on self-care, sensation, social interaction and language subscales of the ABC scale (P < 0.05), as well as a significant reduction in the total score of the CARS (P < 0.05). The ESDM group had a significantly greater reduction in the score on social interaction subscale than the conventional rehabilitation group (P < 0.05). The ESDM+VitD3 group had a significantly greater reduction in the score on social interaction subscale than the other two groups (P < 0.05). Conclusions ESDM can effectively improve the clinical symptoms of toddlers with ASD, with a significantly better clinical effect in improving social interaction and somatic movement than conventional rehabilitation. ESDM combined with VitD3 has a significantly better clinical effect in improving social communication skills and may be one of the best strategies for improving the clinical symptoms of toddlers with ASD.
FENG Jun-Yan,LI Hong-Hua,SHAN Ling et al. Clinical effect of vitamin D3 combined with the Early Start Denver Model in the treatment of autism spectrum disorder in toddlers[J]. CJCP, 2019, 21(4): 337-341.
FENG Jun-Yan,LI Hong-Hua,SHAN Ling et al. Clinical effect of vitamin D3 combined with the Early Start Denver Model in the treatment of autism spectrum disorder in toddlers[J]. CJCP, 2019, 21(4): 337-341.
Baio J, Wiggins L, Christensen DL, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years -Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2014[J]. MMWR Surveill Summ, 2018, 67(6):1-23.
[2]
Jia F, Wang B, Shan L, et al. Core symptoms of autism improved after vitamin D supplementation[J]. Pediatrics, 2015, 135(1):e196-e198.
[3]
Feng J, Shan L, Du L, et al. Clinical improvement following vitamin D3 supplementation in autism spectrum disorder[J]. Nutr Neurosci, 2017, 20(5):284-290.
[4]
Kočovská E, Fernell E, Billstedt E, et al. Vitamin D and autism:clinical review[J]. Res Dev Disabil, 2012, 33(5):1541-1550.
[5]
Guillot X, Semerano L, Saidenberg-Kermanac'h N, et al. Vitamin D and inflammation[J]. Joint Bone Spine, 2010, 77(6):552-557.
[6]
Neve A, Corrado A, Cantatore FP. Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis[J]. Clin Exp Med, 2014, 14(3):275-283.
[7]
Mostafa GA, Al-Ayadhi LY. The possible relationship between allergic manifestations and elevated serum levels of brain specific auto-antibodies in autistic children[J]. J Neuroimmunol, 2013, 261(1-2):77-81.
[8]
Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1:relevance for autism[J]. FASEB J, 2014, 28(6):2398-2413.
[9]
Vivanti G, Dissanayake C, Duncan E, et al. Outcomes of children receiving Group-Early Start Denver Model in an inclusive versus autism-specific setting:a pilot randomized controlled trial[J]. Autism, 2018:1362361318801341. doi:10.1177/1362361318801341.[Epub ahead of print].
Cannell JJ, Hollis BW. Use of vitamin D in clinical practice[J]. Altern Med Rev, 2008, 13(1):6-20.
[13]
Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism:the Early Start Denver Model[J]. Pediatrics, 2009, 125(1):e17-e23.
[14]
Vivanti G, Dissanayake C, Zierhut C, et al. Brief report:predictors of outcomes in the Early Start Denver Model delivered in a group setting[J]. J Autism Dev Disord, 2013, 43(7):1717-1724.
[15]
Estes A, Munson J, Rogers SJ, et al. Long-term outcomes of early intervention in 6-year-old children with autism spectrum disorder[J]. J Am Acad Child Adolesc Psychiatry, 2015, 54(7):580-587.
[16]
Mostafa GA, Al-Ayadhi LY. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism:relation to autoimmunity[J]. J Neuroinflammation, 2012, 9:201.
[17]
Molloy CA, Kalkwarf HJ, Manning-Courtney P, et al. Plasma 25(OH)D concentration in children with autism spectrum disorder[J]. Dev Med Child Neurol, 2012, 52(10):969-971.
[18]
Tostes MH, Polonini HC, Gattaz WF, et al. Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism[J]. Trends Psychiatry Psychother, 2012, 34(3):161-163.
[19]
Neumeyer AM, Gates A, Ferrone C, et al. Bone density in peripubertal boys with autism spectrum disorders[J]. J Autism Dev Disord, 2013, 43(7):1623-1629.
[20]
Gong ZL, Luo CM, Wang L, et al. Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders[J]. Neuroreport, 2014, 25(1):23-27.
